Author Takeda, Tatsuaki| Matsumoto, Jun| Sakai, Tomonori| Iwata, Naohiro| Hamano, Hirofumi| Koyama, Toshihiro| Ariyoshi, Noritaka| Zamami, Yoshito|
Keywords adverse event breast cancer pertuzumab trastuzumab VigiBase
Note This is the peer reviewed version of the following article: [Takeda T, Matsumoto J, Sakai T, et al. Comprehensive analysis of adverse event profile changes with pertuzumab addition to trastuzumab-based breast cancer therapy: Disproportionality analysis using VigiBase. Br J Clin Pharmacol. 2025; 1-13. doi:10.1002/bcp.70094], which has been published in final form at [https://doi.org/10.1002/bcp.70094]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.| This fulltext file will be available in May. 2026.|
Published Date 2025-05-08
Publication Title British Journal of Clinical Pharmacology
Publisher Wiley
ISSN 0306-5251
NCID AA00574388
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2025 British Pharmacological Society.
File Version author
PubMed ID 40344285
DOI 10.1002/bcp.70094
Web of Science KeyUT 001483932800001
Related Url isVersionOf https://doi.org/10.1002/bcp.70094
FullText URL fulltext20240206-02.pdf
Author Takeda, Tatsuaki| Sugimoto, Shiho| Matsumoto, Jun| Iwata, Naohiro| Nakamoto, Akihiko| Ozaki, Aya Fukuma| Hamano, Hirofumi| Ariyoshi, Noritaka| Zamami, Yoshito|
Keywords Abemaciclib Adverse event Breast cancer Cyclin-dependent kinase 4/6 inhibitor Palbociclib
Note This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: http://dx.doi.org/10.1007/s11096-023-01687-6| This fulltext file will be available in Jan. 2025.|
Published Date 2024-01-19
Publication Title International Journal of Clinical Pharmacy
Volume volume46
Issue issue2
Publisher Springer Science and Business Media LLC
Start Page 536
End Page 541
ISSN 2210-7703
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024
File Version author
PubMed ID 38240964
DOI 10.1007/s11096-023-01687-6
Web of Science KeyUT 001145361500002
Related Url isVersionOf https://doi.org/10.1007/s11096-023-01687-6
FullText URL fulltext20230207-1.pdf
Author Matsumoto, Jun| Nishimoto, Anzu| Watari, Shogo| Ueki, Hideo| Shiromizu, Shoya| Iwata, Naohiro| Takeda, Tatsuaki| Ushio, Soichiro| Kajizono, Makoto| Fujiyoshi, Masachika| Koyama, Toshihiro| Araki, Motoo| Wada, Koichiro| Zamami, Yoshito| Nasu, Yasutomo| Ariyoshi, Noritaka|
Keywords Genetic variant Polymorphism Renal cell carcinoma Survival UDP-glucuronosyltransferase
Note This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: http://dx.doi.org/10.1007/s11010-022-04637-4|
Published Date 2022-12-26
Publication Title Molecular and Cellular Biochemistry
Volume volume478
Issue issue8
Publisher Springer Science and Business Media LLC
Start Page 1779
End Page 1790
ISSN 0300-8177
NCID AA00745800
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022
File Version author
PubMed ID 36571650
DOI 10.1007/s11010-022-04637-4
Web of Science KeyUT 000904010400001
Related Url isVersionOf https://doi.org/10.1007/s11010-022-04637-4
FullText URL fulltext20210603-2.pdf
Author Matsumoto, Jun| Kotera, Yumi| Watari, Shogo| Takeuchi, Koichi| Ueki, Hideo| Koyama, Toshihiro| Wada, Koichiro| Fujiyoshi, Masachika| Nasu, Yasutomo| Ariyoshi, Noritaka|
Keywords human cytochrome P450 CYP3A renal cell carcinoma treatment outcome
Published Date 2021-5
Publication Title Anticancer Research
Volume volume41
Issue issue5
Publisher International Institute of Anticancer Research
Start Page 2511
End Page 2521
ISSN 0250-7005
NCID AA10625860
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders Copyright © 2021 by The International Institute of Anticancer Research
File Version publisher
PubMed ID 33952479
DOI 10.21873/anticanres.15029
Web of Science KeyUT 000648665800021
Related Url isVersionOf https://doi.org/10.21873/anticanres.15029
FullText URL fulltext_.pdf
Author Matsumoto, Jun| San, Su Nwe| Fujiyoshi, Masachika| Kawauchi, Ayano| Chiba, Natsumi| Tagai, Ran| Sanbe, Ryoko| Yanaka, Shiho| Sakaue, Hiroaki| Kato, Yoshinori| Nakamura, Hiroyoshi| Yamada, Harumi| Ariyoshi, Noritaka|
Keywords Genetic markers Haplotypes
Published Date 2019-10-23
Publication Title Journal of Human Genetics
Volume volume65
Publisher Japan Society of Human Genetics
Start Page 143
End Page 153
ISSN 1434-5161
NCID AA11206160
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
File Version author
PubMed ID 31645655
DOI 10.1038/s10038-019-0685-2
Web of Science KeyUT 000513167200007
Related Url isVersionOf https://doi.org/10.1038/s10038-019-0685-2